Numerous studies have unequivocally identified ABC transporters as pivotal players in mediating cancer multidrug resistance (MDR) development, such as P-glycoprotein (P-gp, also named MDR1), multidrug resistance-associated protein 1 (MRP1), and breast cancer resistance protein (BCRP) [31]. This evidence concerns the gene ABCG2 and cancer.